Autobahn Therapeutics
Autobahn Therapeutics is a remyelination program for multiple sclerosis.
1
Funding Rounds
$76.0m
Money raised
Overview
Autobahn Therapeutics is a remyelination program for multiple sclerosis.
- Website:
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Autobahn Therapeutics has raised a total of $76m in funding over 1 rounds.
Key Insights:
- Autobahn Therapeutics Series B round, June 2020: $76m
Autobahn Therapeutics Series B round, June 2020
$76m
Industries
Autobahn Therapeutics is active in the following industries:
- Synthetic chemistry
- Regenerative medicine
- Biotechnology